Platinum(IV) derivatives of oxaliplatin: Cellular effects and in vivo potency

S. Goeschl; V. Pichler; E. Brynzak; P. Heffeter; U. Jungwirth; M. A. Jakupec; W. Berger; Mathea Sophia Galanski; B. K. Keppler

Platinum(IV) derivatives of oxaliplatin: Cellular effects and in vivo potency

S. Goeschl, V. Pichler, E. Brynzak, P. Heffeter, U. Jungwirth, M. A. Jakupec, W. Berger, Mathea Sophia Galanski, B. K. Keppler

Publications: Contribution to journal › Meeting abstract/Conference paper › Peer Reviewed

Original language	English
Pages (from-to)	22-22
Number of pages	1
Journal	European Journal of Cancer
Volume	50
Publication status	Published - Nov 2014
Event	26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - Barcelona, Spain Duration: 18 Nov 2014 → 21 Nov 2014

Austrian Fields of Science 2012

104003 Inorganic chemistry
301904 Cancer research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{9a51b00231fa41dcb6782fe8191d2fe9,

title = "Platinum(IV) derivatives of oxaliplatin: Cellular effects and in vivo potency",

author = "S. Goeschl and V. Pichler and E. Brynzak and P. Heffeter and U. Jungwirth and Jakupec, {M. A.} and W. Berger and Galanski, {Mathea Sophia} and Keppler, {B. K.}",

note = " Accession Number: WOS:000347755700053 ; 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics ; Conference date: 18-11-2014 Through 21-11-2014",

year = "2014",

month = nov,

language = "English",

volume = "50",

pages = "22--22",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "ELSEVIER SCI LTD",

}

TY - JOUR

T1 - Platinum(IV) derivatives of oxaliplatin: Cellular effects and in vivo potency

AU - Goeschl, S.

AU - Pichler, V.

AU - Brynzak, E.

AU - Heffeter, P.

AU - Jungwirth, U.

AU - Jakupec, M. A.

AU - Berger, W.

AU - Galanski, Mathea Sophia

AU - Keppler, B. K.

N1 - Accession Number: WOS:000347755700053

PY - 2014/11

Y1 - 2014/11

M3 - Meeting abstract/Conference paper

SN - 0959-8049

VL - 50

SP - 22

EP - 22

JO - European Journal of Cancer

JF - European Journal of Cancer

T2 - 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Y2 - 18 November 2014 through 21 November 2014

ER -